Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine

International Journal of Neuropsychopharmacology

Volumn 3, Issue 3, 2000, Pages 221-228

  Gommans, Jan ^a   Hijzen, Theo H ^a   Maes, Robert A ^a   Olivier, Berend ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PSYCHOGENICS INC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(1A) receptor; 5 HT(1B) receptor; Drug discrimination; Eltoprazine; Flesinoxan

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ANPIRTOLINE; BUSPIRONE; ELTOPRAZINE; FLESINOXAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0033799217     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145700001991     Document Type: Article

References (25)

1. 8-Hydroxy-2-2(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
2. Pharmacology of the novel 5-hydroxytryptamine(1A) receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamine)tetralin-induced effects
3. Flesinoxan treatment of generalized anxiety disorder: A fixed dose, placebo controlled study
4. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT(1A) receptor antagonist
5. Discriminative stimulus properties of flesinoxan: Effects of enantiomers, (S)-UH 301 and WAY-100625
6. Discriminative stimulus properties of eltoprazine
7. An open study of oral flesinoxan, a 5-HT(1A) receptor agonist, in treatment resistant depression
8. A conceptualization of drug discrimination learning
9. The putative 5-HT(1A) receptor antagonist DU1 25530 blocks the discriminative stimulus of the 5-HT(1A) receptor agonist flesinoxan in pigeons
10. New animal models of anxiety
11. Serenics
12. GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test
13. Similarities and differences between behavioral control by drug-produced stimuli and by sensory stimuli
14. Preclinical pharmacology' of flesinoxan: A potential anxiolytic and anti-depressant drug
15. Neurochemical profile of eltoprazine
16. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus
17. GR 127935: A potent and selective 5-HT(1D) receptor agonist
18. The serotonin 5-HT(1D) receptor: A progress review
19. Flesinoxan lowers blood pressure and heart rate in cats via 5-HT(1A) receptors
20. Further investigation on the discriminative stimulus properties of the serotonergic compound eltoprazine
21. Discriminative stimulus properties of the serotonergic compound eltoprazine
22. Discriminative stimulus properties of the serotonergic compound flesinoxan
23. Further characterization of the discriminative stimulus induced by flesinoxan
24. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from s(+)-MDA